Samsrita Labs Reports ₹8.69 Crore Loss for FY26, Eyes Diversification

Samsrita Labs Limited reported a standalone net loss of ₹8.686 crore for the financial year ended March 31, 2026.

Consolidated operations also registered a loss of ₹8.1605 crore for the same period.

Reader Takeaway: Continued annual losses persist, but a strategic pivot to new product categories may offer future growth.

What just happened

Samsrita Labs Limited announced its financial results for the fiscal year ended March 31, 2026. The company reported a standalone net loss of ₹8.686 crore (₹868.60 lakh) and a consolidated loss of ₹8.1605 crore (₹816.05 lakh). The company's revenue from operations for the quarter ended March 31, 2026, was ₹0.0181 crore (₹1.81 lakh). The standalone Earnings Per Share (EPS) for the year was ₹-4.25.

Additionally, the Board of Directors appointed M/s Tungala & Co. as the internal auditor for the financial year 2026-27. They also approved the write-off of ₹2.0899089 crore (₹208.99089 lakh) of trade receivables and doubtful debts from M/s Mangala Savitri Bizcon Private Limited.

Why this matters

The sustained losses indicate ongoing financial challenges for Samsrita Labs. However, the company's stated intention to expand into pet and home need products in FY 2026-27 signals a strategic shift aimed at diversifying revenue streams and potentially improving future profitability.

The backstory

Samsrita Labs operates primarily within the Health Care Sector, as indicated by its single reportable segment. The company has been facing profitability challenges, as reflected in the yearly losses reported.

What changes now

With the appointment of a new internal auditor and the strategic decision to explore new business segments, the company is positioning itself for a potential turnaround. Investors will be watching the execution of the planned diversification into pet and home need products.

Risks to watch

The significant write-off of trade receivables amounting to over ₹2 crore points to potential issues with past credit management and asset recovery. Continued financial losses remain a primary concern for stakeholders.

Peer comparison

(No direct peer comparison data is available in the filing for this specific update.)

Context metrics (time-bound)

• Standalone Yearly Loss (FY26): ₹8.686 crore
• Consolidated Yearly Loss (FY26): ₹8.1605 crore
• Trade Receivables Write-off: ₹2.0899089 crore

What to track next

Investors should closely monitor the company's progress in diversifying its business operations into pet and home need products. Performance updates in subsequent quarters will be crucial to assess the impact of this strategic move on the company's financial health.